29 Views | 50 Downloads
Correspondence to: Pan Pantziarka. Email: anticancer.org.uk@gmail.com
This work would not be as extensive without the contribution of multiple collaborators, researchers and clinicians who share our interest in drug repurposing.
We are grateful to Richard Kast, Andrew Wilcock, Michael Jameson, Lars Søraas, Nicolas André, Albrecht Reichle, Richard Sullivan, Bjørn Tore Gjertsen, Peter Nygren, our colleagues at the Anticancer Fund and the team at ecancermedicalscience … and many others who have shared their findings with us to make this list as complete as possible.
The authors declare that they have no competing interests.
All the authors are associated with not for profit organisations that aim to repurpose drugs for oncology treatments.
VPS is also a scientific advisory board member of Berg Health and Mitra Biotech.
© The authors.